Results 161 to 170 of about 164,343 (265)

Integrated Network Pharmacology and Machine Learning to Reveal the Mechanisms of Schisandrin A Against Triple-Negative Breast Cancer. [PDF]

J Cell Mol Med
Xu M, Zhang Y, Mei R, Xue T, Cai H, Zhou Y, Guo J.   +6 more
europepmc   +1 more source

Inhibition of KDEL Receptors Remodels the Tumor Microenvironment for T Cell Independent Tumor Regression

Advanced Science, EarlyView.
Inhibition of KDELR2 in a small fraction of tumor cells generates sustainable immunogenic cell death conditions within the tumor microenvironment. These conditions promote the regression of tumors in a T cell independent manner. During regression, macrophages prime T cells that subsequently provide systemic protection against recurrence. The potency of
Shakti P Pattanayak, Hong Wang, Belinda Willard, Timothy A. Chan, William C Merrick, Zheng‐Rong Lu, Boaz Tirosh   +6 more
wiley   +1 more source

Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population: Phenotypic Characterization. [PDF]

Genes (Basel)
Garza-Rodríguez ML, Vargas-Márquez EAA, Aguilar D, Trujillo-Bornios S, Gallardo-Blanco HL, Vidal-Gutiérrez O, Pérez-Ibave DC, Burciaga-Flores CH.   +7 more
europepmc   +1 more source

A Chemically Defined Four‐Component Self‐Adjuvanting Tn Vaccine Activating Mincle, FcγR, and CD206 for Enhanced Antitumor Immunity

Advanced Science, EarlyView.
A fully synthetic four‐component vaccine has been developed combining Tn antigen, vizantin (Mincle agonist), rhamnose (antibody recruitment), and mannose (CD206 targeting). By synergistically activating Mincle, FcγR, and CD206 pathways, it elicits strong IgG switching and cytotoxic T‐cells, significantly inhibiting tumors in mice.
Wenbo Ming, Renyu Zhang, Xiaohui Li, Guiqi Li, Yu Niu, Deying Yang, Xiang Luo, Jun Liao, Zhongqiu Liu, Guochao Liao   +9 more
wiley   +1 more source

Microglandular adenosis, triple negative breast carcinoma and DNA repair defects. [PDF]

J Clin Pathol
Bedell M, da Silva EM, Selenica P, Gazzo AM, Blanco Heredia J, Basili T, Elishaev E, Harinath L, Diego E, Tageja N, Weigelt B, Reis-Filho JS, Bhargava R.   +12 more
europepmc   +1 more source

The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

American Journal of Pathology, 2017
F. Geyer, F. Pareja, B. Weigelt, E. Rakha, I. Ellis, S. Schnitt, J. Reis-Filho   +6 more
semanticscholar   +1 more source

Ovarian Cancer Diagnosis and Chemoresistance Prediction Model Based on cfRNA Molecular Signature

Advanced Science, EarlyView.
A deep learning model analyzes cfRNA profiles extracted from the blood of OVCA patients. This innovative approach distinguishes OVCA from healthy controls with high accuracy. Crucially, it reliably predicts patient response to chemotherapy (sensitive versus resistant subgroups).
Qinhao Guo, Yangyang Zhang, Yongcheng Jin, Siwei Deng, Yongqi Chen, Zheng Feng, Hao Wen, Liu Wang, Yilin Li, Fanghong Ou, Yong Shen, Haiming Li, Tianyao Zhou, Xingzhu Ju, Xiaohua Wu   +14 more
wiley   +1 more source

Nivolumab-associated hypopituitarism in a 61-year-old woman with metastatic triple-negative breast. [PDF]

Oxf Med Case Reports
Lomidze K, Gordeladze M, Kikodze N, Charkviani N, Chikovani T.   +4 more
europepmc   +1 more source

Material‐Encoded Synchronization of Immunogenic Cell Death With Adenosine A2A Receptor Blockade Reprograms the Tumor Microenvironment

Advanced Science, EarlyView.
A bismuth–copper diselenide–based nanoplatform (BSCS@PHY) coordinates immunogenic cell death with local A2A receptor blockade in 4T1 tumors. Thermally triggered shell melting exposes catalytic surfaces for glutathione depletion and chemodynamic ROS generation, while co‐delivering an A2AR antagonist and yeast‐wall adjuvant to enhance dendritic‐cell ...
Xiangting Yi, Hanlou Yang, Junting Huang, Pengfei Wu, Shiying Zhou, Zunde Liao, Min Han, Zishan Chen, Xiaoyu Huang, Nan Ma, Jie Zhou, Mingqiang Li, Yiling Zhong   +12 more
wiley   +1 more source

Clinical Implications of p16 Evaluation in a Purposively Sampled Cohort of High-Risk Breast Cancer Phenotypes. [PDF]

Int J Mol Sci
Anton SC, Nedelcu AH, Anton CR, Morariu ID, Lupu A, Dăscălescu G, Ciobîcă A, Lupu VV, Knieling A, Crauciuc DV, Eduard C, Tirnovanu M, Dondiuc I, Ilea C, Anton E.   +14 more
europepmc   +1 more source